Evidence map›Paper›PMID 24475281›Full record

ArticlePloS one2014

Lethal giant larvae 1 tumour suppressor activity is not conserved in models of mammalian T and B cell leukaemia.

Edwin D Hawkins, Jane Oliaro, Kelly M Ramsbottom, Stephen B Ting, Faruk Sacirbegovic, Michael Harvey, Tanja Kinwell, Jacques Ghysdael, Ricky W Johnstone, Patrick O Humbert and 1 more

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Orchestrating Lymphocyte Polarity in Cognate Immune Cell-Cell Interactions.International review of cell and molecular biology · 2016
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Edwin D HawkinsCancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
Jane OliaroCancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
Kelly M RamsbottomCancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
Stephen B TingStem Cell Research Group, Australian Centre for Blood Diseases, Monash University and Alfred Health, Melbourne, Victoria, Australia.
Faruk SacirbegovicCancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
Michael HarveyCancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
Tanja KinwellSir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia ; Cell Cycle and Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Jacques GhysdaelInstitut Curie, Centre Universitaire, Bat 110 91405, Orsay, France ; Centre National de la Recherche Scientifique UMR 3306, Orsay, France ; INSERM (Institut National de la Santé et de la Recherche Médicale) U1005, Orsay, France.
Ricky W JohnstoneCancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
Patrick O HumbertSir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia ; Cell Cycle and Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sarah M RussellCancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia ; Centre for Micro-Photonics, Swinburne University of Technology, Hawthorn, Victoria, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In epithelial and stem cells, lethal giant larvae (Lgl) is a potent tumour suppressor, a regulator of Notch signalling, and a mediator of cell fate via asymmetric cell division. Recent evidence suggests that the function of Lgl is conserved in mammalian haematopoietic stem cells and implies a contribution to haematological malignancies. To date, direct measurement of the effect of Lgl expression on malignancies of the haematopoietic lineage has not been tested. In Lgl1⁻/⁻ mice, we analysed the development of haematopoietic malignancies either alone, or in the presence of common oncogenic lesions. We show that in the absence of Lgl1, production of mature white blood cell lineages and long-term survival of mice are not affected. Additionally, loss of Lgl1 does not alter leukaemia driven by constitutive Notch, c-Myc or Jak2 signalling. These results suggest that the role of Lgl1 in the haematopoietic lineage might be restricted to specific co-operating mutations and a limited number of cellular contexts.

Indexed as

Disease Models, AnimalAnimalsBone Marrow TransplantationCell LineageCytoskeletal ProteinsDNA PrimersHematopoietic Stem CellsHomeodomain ProteinsKaplan-Meier EstimateLeukemia, B-CellLeukemia, T-CellMiceMice, KnockoutReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionTumor Suppressor ProteinsCytoskeletal ProteinsDNA PrimersHomeodomain ProteinsLlgl1 protein, mouseTumor Suppressor Proteins

Identifiers

PMID24475281
PMCPMC3903681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.